Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1957 1
1958 1
1959 6
1960 7
1961 4
1962 19
1963 9
1964 16
1965 20
1966 19
1967 45
1968 37
1969 49
1970 16
1971 23
1972 24
1973 20
1974 19
1975 6
1976 2
1977 4
1978 14
1979 8
1980 11
1981 10
1982 14
1983 51
1984 112
1985 110
1986 114
1987 153
1988 156
1989 174
1990 206
1991 204
1992 220
1993 252
1994 247
1995 250
1996 251
1997 251
1998 215
1999 227
2000 239
2001 272
2002 272
2003 334
2004 355
2005 390
2006 395
2007 420
2008 441
2009 467
2010 547
2011 597
2012 656
2013 642
2014 657
2015 791
2016 665
2017 671
2018 721
2019 840
2020 1104
2021 1182
2022 1462
2023 1295
2024 428

Text availability

Article attribute

Article type

Publication date

Search Results

17,079 results

Results by year

Filters applied: . Clear all
Page 1
Prophylaxis and management of graft-versus-host disease after stem-cell transplantation for haematological malignancies: updated consensus recommendations of the European Society for Blood and Marrow Transplantation.
Penack O, Marchetti M, Aljurf M, Arat M, Bonifazi F, Duarte RF, Giebel S, Greinix H, Hazenberg MD, Kröger N, Mielke S, Mohty M, Nagler A, Passweg J, Patriarca F, Ruutu T, Schoemans H, Solano C, Vrhovac R, Wolff D, Zeiser R, Sureda A, Peric Z. Penack O, et al. Lancet Haematol. 2024 Feb;11(2):e147-e159. doi: 10.1016/S2352-3026(23)00342-3. Epub 2024 Jan 3. Lancet Haematol. 2024. PMID: 38184001 Review.
Improving Outcomes in Chronic Graft-vs-Host Disease.
Mitchell SA, Cowen EW. Mitchell SA, et al. JAMA Dermatol. 2024 Apr 1;160(4):388-391. doi: 10.1001/jamadermatol.2023.6276. JAMA Dermatol. 2024. PMID: 38416464 No abstract available.
Ocular graft versus host disease.
Nair S, Vanathi M. Nair S, et al. Indian J Ophthalmol. 2024 Jan 1;72(1):149-150. doi: 10.4103/IJO.IJO_2884_23. Epub 2023 Dec 22. Indian J Ophthalmol. 2024. PMID: 38131598 Free PMC article. No abstract available.
Low-dose rituximab in steroid-refractory chronic graft-versus-host disease.
Colunga-Pedraza PR, Barbosa-Castillo LM, Coronado-Alejandro EU, Vaquera-Alfaro HA, López-Reyna IG, Colunga-Pedraza JE, Gómez-Almaguer D. Colunga-Pedraza PR, et al. Transpl Immunol. 2023 Dec;81:101959. doi: 10.1016/j.trim.2023.101959. Epub 2023 Nov 14. Transpl Immunol. 2023. PMID: 37972876
Data-driven grading of acute graft-versus-host disease.
Bayraktar E, Graf T, Ayuk FA, Beutel G, Penack O, Luft T, Brueder N, Castellani G, Reinhardt HC, Kröger N, Beelen DW, Turki AT. Bayraktar E, et al. Nat Commun. 2023 Nov 28;14(1):7799. doi: 10.1038/s41467-023-43372-2. Nat Commun. 2023. PMID: 38017035 Free PMC article.
17,079 results
You have reached the last available page of results. Please see the User Guide for more information.